Wird geladen...
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Doxorubicin is a commonly used chemotherapeutic agent for the treatment of a range of cancers, but despite its success in improving cancer survival rates, doxorubicin is cardiotoxic and can lead to congestive heart failure. Therapeutic options for this patient group are limited to standard heart fai...
Gespeichert in:
| Veröffentlicht in: | Cardiovasc Drugs Ther |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer US
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7125062/ https://ncbi.nlm.nih.gov/pubmed/32034646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-020-06941-x |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|